“Therapeutic Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”, Althea Med J, vol. 12, no. 3, pp. 161–171, Sep. 2025, doi: 10.15850/amj.v12n3.4209.